A novel mechanism for immune regulation after human lung transplantation
Comparing BOS Incidence Between HCT Donor Types | Cancer Nursing Today
American Thoracic Society - Up to half of lung transplant recipients develop bronchiolitis obliterans syndrome within five years of transplantation. Learn more: http://thoracic.org/patients/patient-resources/resources/bronchiolitis-obliterans-syndrome ...
A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation - Neurohr - 2022 - American Journal of Transplantation - Wiley Online Library
Lung allograft loss: naming helps seeing… and vice versa! | European Respiratory Society
Chronic lung allograft dysfunction phenotypes and treatment - Verleden - Journal of Thoracic Disease
Bronchiolitis obliterans syndrome–free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis - ScienceDirect
The Lung Transplant Foundation to Host Externally-Led Patient-Focused Drug Development Meeting to Help Educate FDA on Living with Bronchiolitis Obliterans Syndrome (BOS)
Imaging Course of Lung Transplantation: From Patient Selection to Postoperative Complications | RadioGraphics
Global Proteomics Analysis of Circulating Extracellular Vesicles Isolated from Lung Transplant Recipients | ACS Omega
BOS – Lung Transplant Foundation
BOS – Lung Transplant Foundation
Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single‐center study - Verleden - 2020 - Clinical Transplantation - Wiley Online Library
Bronchiolitis Obliterans Syndrome (BOS), Bronchiolitis Obliterans Organizing Pneumonia (BOOP), and Other Late-Onset Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation - ScienceDirect
The Surfactant System and Its Relationship to Risk Factors for BOS | Download Scientific Diagram
Pulmonary graft-versus-host disease and chronic lung allograft dysfunction: two sides of the same coin? - The Lancet Respiratory Medicine
Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and ...
Developing a novel inhaled therapeutic for the treatment of bronchiolitis obliterans syndrome - Research Outreach
Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review | European Respiratory Society